Fluticasone furoate/Vilanterol (Breo ellipta)
The objective of this review was to perform a systematic review of the beneficial and harmful effects of fluticasone furoate/vilanterol (FF/V; Breo Ellipta) for the treatment of patients with COPD, including chronic bronchitis and/or emphysema
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, November 2016
|
Series: | Common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this review was to perform a systematic review of the beneficial and harmful effects of fluticasone furoate/vilanterol (FF/V; Breo Ellipta) for the treatment of patients with COPD, including chronic bronchitis and/or emphysema |
---|---|
Physical Description: | 1 PDF file (84 pages) illustrations |